Key terms

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BLRX news

Yesterday 11:05am ET Buy Rating on Bioline RX Ltd for Breakthrough Stem Cell Mobilization and Enhanced Apheresis Efficiency by TipRanks Yesterday 8:27am ET BioLineRx Enhances Multiple Myeloma Treatment by TipRanks Apr 01 11:27am ET BiolineRx Ltd. Completes Significant Securities Offering by TipRanks Apr 01 9:05am ET BioLineRx to sell 7.5M ADSs at 80c in registered direct offering by TipRanks Mar 28 10:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 26 11:45am ET Buy Rating Affirmed for BioLineRx: Strong Financials and Expanding Market Presence Fuel Analyst Optimism by TipRanks Mar 26 8:05am ET Options Volatility and Implied Earnings Moves Today, March 26, 2024 by TipRanks Mar 26 7:59am ET BioLineRx Announces Major Commercial Milestones by TipRanks Mar 25 8:00am ET Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024 by TipRanks Mar 04 7:12am ET BioLineRx receives Notice of Allowance from USPTO for a patent by TipRanks Feb 29 6:27am ET Positive Outlook for Bioline RX with Promising Phase 2 Trial Results and New Product Launch: A Buy Rating by TipRanks Feb 28 11:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 28 11:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 28 7:22am ET BioLineRx announces dosing of frist patient in CheMo4METPANC Phase 2 trial by TipRanks

No recent press releases are available for BLRX

BLRX Financials

1-year income & revenue

Key terms

BLRX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BLRX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching